<?xml version='1.0' encoding='utf-8'?>
<document id="12472986"><sentence text="Effect of proguanil interaction on bioavailability of cloxacillin."><entity charOffset="10-19" id="DDI-PubMed.12472986.s1.e0" text="proguanil" /><entity charOffset="54-65" id="DDI-PubMed.12472986.s1.e1" text="cloxacillin" /><pair ddi="false" e1="DDI-PubMed.12472986.s1.e0" e2="DDI-PubMed.12472986.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12472986.s1.e0" e2="DDI-PubMed.12472986.s1.e1" /></sentence><sentence text="To investigate a potential drug-drug interaction between proguanil (PG) and cloxacillin (Clox)"><entity charOffset="57-66" id="DDI-PubMed.12472986.s2.e0" text="proguanil" /><entity charOffset="68-70" id="DDI-PubMed.12472986.s2.e1" text="PG" /><entity charOffset="76-87" id="DDI-PubMed.12472986.s2.e2" text="cloxacillin" /><pair ddi="false" e1="DDI-PubMed.12472986.s2.e0" e2="DDI-PubMed.12472986.s2.e0" /><pair ddi="false" e1="DDI-PubMed.12472986.s2.e0" e2="DDI-PubMed.12472986.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12472986.s2.e0" e2="DDI-PubMed.12472986.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12472986.s2.e1" e2="DDI-PubMed.12472986.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12472986.s2.e1" e2="DDI-PubMed.12472986.s2.e2" /></sentence><sentence text=" Seven healthy adult volunteers received a single oral dose of Clox plus coadministration of single oral doses of PG and Clox in a simple cross-over manner after a wash-out period of 1 week"><entity charOffset="114-124" id="DDI-PubMed.12472986.s3.e0" text="PG" /></sentence><sentence text=" Total urine voided was collected at predetermined time intervals over 12 h" /><sentence text=" Amount of Clox in urine was determined by a reversed-phase high-pressure liquid chromatography method" /><sentence text="" /><sentence text="The mean maximum excretion rate [(dDu/dt)max] of Clox when taken alone was 16" /><sentence text="13 +/- 2" /><sentence text="92 mg/h at tmax of 1" /><sentence text="86 +/- 01" /><sentence text="07 hours, whereas in the presence of PG, it was 7"><entity charOffset="37-39" id="DDI-PubMed.12472986.s11.e0" text="PG" /></sentence><sentence text="72 +/- 3" /><sentence text="24 mg/h at tmax of 2" /><sentence text="43 +/- 00" /><sentence text="98 hours (P &lt; 0" /><sentence text="0001)" /><sentence text=" The total amount of Clox excreted in urine (Du infinity) in 12 h was markedly reduced by coadministration with PG by up to 48% with Du infinity of 49"><entity charOffset="112-114" id="DDI-PubMed.12472986.s17.e0" text="PG" /></sentence><sentence text="57 +/- 8" /><sentence text="16 mg after Clox alone and 25" /><sentence text="81 +/- 8" /><sentence text="46 mg in the presence of PG (P &lt; 0"><entity charOffset="25-26" id="DDI-PubMed.12472986.s21.e0" text="PG" /></sentence><sentence text="0001)" /><sentence text=" The tmax and t1/2-values obtained from the excretion rate plot were lengthened by 23 and 34%, respectively, in the presence of PG but the differences were not statistically significant (P &gt; 0"><entity charOffset="128-129" id="DDI-PubMed.12472986.s23.e0" text="PG" /></sentence><sentence text="05)" /><sentence text="" /><sentence text="These pharmacokinetic values indicate slowed and diminished absorption (bioavailability) of Clox when concurrently administered with PG"><entity charOffset="133-134" id="DDI-PubMed.12472986.s26.e0" text="PG" /></sentence><sentence text=" The clinical implication is unknown" /><sentence text=" However, concomitant administration of the two drugs during antibacterial therapy should be done with caution so as to avoid subtherapeutic levels of Clox, which can lead to treatment failure and facilitate drug resistance" /><sentence text="" /></document>